(VIANEWS) – Ship Finance International Limited (SFL), Amgen (AMGN), Zynex (ZYXI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Ship Finance International Limited (SFL)
24.4% sales growth and 11.6% return on equity
SFL Corporation Ltd., a maritime and offshore asset owning and chartering company, engages in the ownership, operation, and chartering out of vessels and offshore related assets on medium and long-term charters. The company operates in various sectors of the maritime, and shipping and offshore industries, including oil transportation, dry bulk shipments, chemical transportation, oil products transportation, container transportation, car transportation, and drilling rigs. As of December 31, 2023, the company owned seven crude oil carriers, six oil product tankers, 15 dry bulk carriers, 32 container vessels, one jack-up drilling rig, one ultra-deepwater drilling rig, and five car carriers. It primarily operates in Bermuda, Canada, Cyprus, Liberia, Namibia, Norway, Singapore, the United Kingdom, and the Marshall Islands. The company was formerly known as Ship Finance International Limited and changed its name to SFL Corporation Ltd. in September 2019. SFL Corporation Ltd. was founded in 2003 and is based in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Ship Finance International Limited has a trailing twelve months EPS of $0.97.
PE Ratio
Ship Finance International Limited has a trailing twelve months price to earnings ratio of 13.57. Meaning, the purchaser of the share is investing $13.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.6%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 107.7% and positive 117.4% for the next.
Volume
Today’s last reported volume for Ship Finance International Limited is 444019 which is 24.28% below its average volume of 586419.
2. Amgen (AMGN)
22.2% sales growth and 72.57% return on equity
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Earnings Per Share
As for profitability, Amgen has a trailing twelve months EPS of $12.48.
PE Ratio
Amgen has a trailing twelve months price to earnings ratio of 21.42. Meaning, the purchaser of the share is investing $21.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 72.57%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22%, now sitting on 29.53B for the twelve trailing months.
Volume
Today’s last reported volume for Amgen is 1865240 which is 36.92% below its average volume of 2957370.
Previous days news about Amgen(AMGN)
- According to Zacks on Thursday, 4 July, "Alongside its first-quarter earnings report, Amgen announced that it has completed an interim analysis of data from a mid-stage study, MariTide. ", "Based on these results, Amgen also initiated activities to expand manufacturing capacity for the drug."
3. Zynex (ZYXI)
20.7% sales growth and 16.75% return on equity
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also supplies electrodes for the delivery of electrical current to the body and batteries for use in electrotherapy products; and distributes Comfortrac for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers blood volume monitor, a non-invasive medical device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Earnings Per Share
As for profitability, Zynex has a trailing twelve months EPS of $0.23.
PE Ratio
Zynex has a trailing twelve months price to earnings ratio of 40.52. Meaning, the purchaser of the share is investing $40.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.75%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 11.1% and positive 60% for the next.
4. Blue Bird Corporation (BLBD)
10.4% sales growth and 153.15% return on equity
Blue Bird Corporation, together with its subsidiaries, designs, engineers, manufactures, and sells school buses in the United States, Canada, and internationally. The company operates through two segments, Bus and Parts. It offers Type C, Type D, and specialty buses; and alternative power options through its propane powered, gasoline powered, compressed natural gas powered, and electric powered school buses, as well as diesel engines. The company also sells replacement bus parts; and provides financing services and extended warranties related to its products. Blue Bird Corporation sells its products through drop ship fulfillment and a network of dealers, as well as directly to fleet operators, the United States government, and state governments; independent service centers; and maintains a parts distribution center. The company was formerly known as Hennessy Capital Acquisition Corp and changed its name to Blue Bird Corporation. Blue Bird Corporation was founded in 1927 and is headquartered in Macon, Georgia.
Earnings Per Share
As for profitability, Blue Bird Corporation has a trailing twelve months EPS of $2.46.
PE Ratio
Blue Bird Corporation has a trailing twelve months price to earnings ratio of 22.06. Meaning, the purchaser of the share is investing $22.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 153.15%.
Yearly Top and Bottom Value
Blue Bird Corporation’s stock is valued at $54.27 at 20:22 EST, under its 52-week high of $59.40 and way above its 52-week low of $17.59.
Previous days news about Blue Bird Corporation(BLBD)
- According to Zacks on Tuesday, 2 July, "Some better-ranked stocks in the auto space are Blue Bird Corporation (BLBD Quick QuoteBLBD – Free Report) , Geely Automobile Holdings Limited (GELYY Quick QuoteGELYY – Free Report) and American Axle & Manufacturing Holdings, Inc. (AXL Quick QuoteAXL – Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. "
- According to Zacks on Wednesday, 3 July, "Some better-ranked stocks in the auto space are Blue Bird Corporation (BLBD Quick QuoteBLBD – Free Report) , Geely Automobile Holdings Limited (GELYY Quick QuoteGELYY – Free Report) and American Axle & Manufacturing Holdings, Inc. (AXL Quick QuoteAXL – Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. "
- According to Zacks on Wednesday, 3 July, "Some better-ranked stocks in the auto space are Blue Bird Corporation (BLBD Quick QuoteBLBD – Free Report) , Geely Automobile Holdings Limited (GELYY Quick QuoteGELYY – Free Report) and American Axle & Manufacturing Holdings, Inc. (AXL Quick QuoteAXL – Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. "
- According to Zacks on Thursday, 4 July, "Some other top-ranked stocks in the auto space are Blue Bird Corporation (BLBD Quick QuoteBLBD – Free Report) and American Axle & Manufacturing Holdings, Inc. (AXL Quick QuoteAXL – Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. "
- According to Zacks on Thursday, 4 July, "Some better-ranked stocks in the auto space are Blue Bird Corporation (BLBD Quick QuoteBLBD – Free Report) , Geely Automobile Holdings Limited (GELYY Quick QuoteGELYY – Free Report) and American Axle & Manufacturing Holdings, Inc. (AXL Quick QuoteAXL – Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. "
5. Scorpio Tankers (STNG)
6% sales growth and 21.39% return on equity
Scorpio Tankers Inc., together with its subsidiaries, engages in the seaborne transportation of crude oi and refined petroleum products in the shipping markets worldwide. As of March 21, 2024, its fleet consisted of 110 owned and leases financed tanker, including 39 LR2, 57 MR, and 14 Handymax with a weighted average age of approximately 8.1 years. Scorpio Tankers Inc. was incorporated in 2009 and is headquartered in Monaco.
Earnings Per Share
As for profitability, Scorpio Tankers has a trailing twelve months EPS of $10.87.
PE Ratio
Scorpio Tankers has a trailing twelve months price to earnings ratio of 7.21. Meaning, the purchaser of the share is investing $7.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.39%.
Volume
Today’s last reported volume for Scorpio Tankers is 942411 which is 32.17% above its average volume of 713025.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.8%, now sitting on 1.35B for the twelve trailing months.
